CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring
· inc., coagusense
AI Briefing
- CoaguSense to acquire DOASENSE's DOAC testing business, expanding its leadership in anticoagulation monitoring.
- The acquisition will enhance CoaguSense's portfolio of products and solutions for patients with DOAC therapy.
- The acquisition is expected to further solidify CoaguSense's position as a leading player in the point-of-care coagulation monitoring market.
Advertisement